+39 02 610346.1 - info@newron.com

Press Releases

Filter by year
  • february212017

    Newron Supports Global Rare Disease Day® 2017 and Rett Syndrome Studies

     

  • january102017

    Seqirus and Zambon enter into a partnership for Parkinson’s disease product in Australia and New Zealand

  • january32017

    Evenamide met study objectives of good tolerability, safety, and preliminary evidence of efficacy as an add-on therapy for the treatment of schizophrenia- unique MoA